The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Neonatology
Volume 12 - 2024 |
doi: 10.3389/fped.2024.1461134
Epidemiology of Neonatal Disorders Attributable to Low Birthweight-Global Burden of Disease Research, 1990 to 2021
Provisionally accepted- 1 Baotou Medical College, Baotou, China
- 2 Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing,China., Beijing, China
- 3 Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education., Beijing, China
- 4 Department of gynecology and obstetrics, Sinopharm Northern Hospital, China., Baotou, China
- 5 Department of public health,Baotou Medical College,Inner Mongolia University of Science and Technology,China., Baotou, China
- 6 International College, Krirk University, Thailand., Bangkok, Thailand
Background: To evaluate global, regional, and national trends in the burden of neonatal diseases attributable to LBW, as well as associated health inequalities, from 1990 to 2021.: Using data from the Global Burden of Disease Study (GBD2021), we analyzed deaths and DALYs due to LBW-attributable neonatal diseases. Data were stratified by gender, geographic region, epidemiological characteristics, and SDI levels. Trends and influencing factors were investigated through Joinpoint regression, health inequality analysis, and frontier modeling. Results: In 2021, the global age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life year (DALY) rate (ASDR) for neonatal diseases associated with low birth weight (LBW) were 22.76 (95% uncertainty interval [UI]: 19.63-26.40) and 2227.54 (95% UI: 1939.96-2563.52) per 100,000, respectively. Over the past 32 years, these rates have consistently declined, with average annual percentage changes (AAPCs) of -1.40 (95% confidence interval [CI]:-1.48 to -1.33) for ASMR and -1.27 (95% CI: -1.34 to -1.21) for ASDR. Notably, absolute health inequality related to the Socio-demographic Index (SDI) has decreased, as indicated by a reduction in DALY disparities between the most and least developed countries from -4216.49 (95% CI: -4558.27 to -3874.71) in 1990 to -2635.35 (95% CI: -2868.40 to -2402.30) in 2021. However, relative health inequality has worsened, with the relative disease burden in low-SDI countries increasing from -33.46% (95% CI: -36.29% to -30.63%) to -40.20% (95% CI: -44.02% to -36.39%).The burden of neonatal diseases remains disproportionately concentrated in low-SDI regions. Frontier analyses highlight opportunities for improvement across development levels. Some low-SDI countries have achieved minimal theoretical disease burdens, whereas certain high-SDI countries lag in reducing their neonatal disease burdens.Over the past 32 years, the global burden of neonatal diseases attributable to LBW has significantly decreased, but inequality in disease burden has intensified. Addressing this disparity requires sustained international and governmental efforts to improve the accessibility, equality, and quality of healthcare for pregnant women and newborns.
Keywords: global health, Epidemiology, Low birthweight, neonatal disease burden, health inequality
Received: 07 Jul 2024; Accepted: 18 Dec 2024.
Copyright: © 2024 Zhang, Luo, Yan, Guo, Wu, Zhang, Zhu and Qiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rui Qiao, Department of public health,Baotou Medical College,Inner Mongolia University of Science and Technology,China., Baotou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.